Literature DB >> 8380788

Human papillomavirus DNA in distant metastases of cervical cancer.

H Ikenberg1, G Teufel, B Schmitt, F Kommoss, B Stanimirovic, A Pfleiderer.   

Abstract

Eighteen distant metastases from cervical cancer to the extrapelvic abdomen, extraabdominal lymph nodes, vulva, suburethral region, skin, and breast in 17 patients were analyzed by Southern blot hybridization under nonstringent and stringent conditions for the prevalence of human papillomavirus (HPV) type 11, 16, 18, 31, 33, and 35 DNA. Fourteen metastases in thirteen patients were HPV-positive. Thirteen tumors contained HPV-16 and one HPV-related sequences with varying copy number. In 9 of 11 cases, where the corresponding primary tumor could be studied, HPV positivity and type were identical. Two HPV-negative primary lesions had HPV-positive metastases; in three cases differences in restriction pattern or copy number were revealed. The HPV status showed no clear association with age of the patient, latency period between primary tumor and metastasis, histological findings, therapy, and clinical course of the disease after metastasis. The rather conserved presence of HPV DNA in distant metastases of cervical carcinoma underlines the importance of these viruses also for the maintenance of the malignant state.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380788     DOI: 10.1006/gyno.1993.1009

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Human papillomavirus detected in a colonic metastasis of cervical adenocarcinoma.

Authors:  A P Damin; G Agnes; C Tarta; P C Contu; T L Ghezzi; L M Kliemann; D C Damin
Journal:  Tech Coloproctol       Date:  2013-04-03       Impact factor: 3.781

2.  International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.

Authors:  Simona Stolnicu; Iulia Barsan; Lien Hoang; Prusha Patel; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Malcolm C Pike; Esther Oliva; Kay J Park; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2018-02       Impact factor: 6.394

3.  LALF32-51-E7 therapeutic vaccine induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the lungs.

Authors:  Milaid Granadillo; Aileen Batte; Aracelys Blanco; Alain B Alfonso; José Suárez; Nelson Merino; Rosalina Carballo; Bárbara O González; Yayrí C Prieto; Laura Varas; Dayana Soler; Miladys Limonta; Maelys Miyares; Lizet Aldana; Isis Torrens
Journal:  Clin Exp Metastasis       Date:  2017-04-17       Impact factor: 5.150

4.  HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study.

Authors:  K Lukaszuk; J Liss; I Wozniak; W Sliwinski; J Emerich; C Wojcikowski
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

5.  Metastatic conversion of cells by expression of human papillomavirus type 16 E6 and E7 genes.

Authors:  L Chen; S Ashe; M C Singhal; D A Galloway; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

6.  A very rare case of HPV-53-related cervical cancer, in a 79-year-old woman with a previous history of negative Pap cytology.

Authors:  Roberta Zappacosta; Giuseppe Lattanzio; Patrizia Viola; Manuel Maria Ianieri; Daniela Maria Pia Gatta; Sandra Rosini
Journal:  Clin Interv Aging       Date:  2014-04-15       Impact factor: 4.458

7.  Detection of high-risk human papillomavirus DNA in tissue from primary cervical cancer tumor, pelvic lymph nodes and recurrent disease.

Authors:  Katrine Fuglsang; Jan Blaakaer; Lone Kjeld Petersen; Else Mejlgaard; Anne Hammer; Torben Steiniche
Journal:  Papillomavirus Res       Date:  2018-12-14

8.  Genomic, transcriptomic, and viral integration profiles associated with recurrent/metastatic progression in high-risk human papillomavirus cervical carcinomas.

Authors:  Jing Jing Liu; Jung Yoon Ho; Jung Eum Lee; Soo Young Hur; Jinseon Yoo; Kyu Ryung Kim; Daeun Ryu; Tae Min Kim; Youn Jin Choi
Journal:  Cancer Med       Date:  2020-10-05       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.